Get started
Author

S.M. Walton

Observed names: S Walton, S. Walton
Observed institution: University of Illinois Chicago
OpenAlex ID: A5111230713
SA50 Claims-Based Estimates of Bleeding Rates in Hemophilia B Patients on Factor IX Therapy in the United States
2022 · J Sarker, S Walton · Value in Health · 1
EE470 The Impact of a Cost Savings Cap on the Cost Effectiveness of Valoctocogene Roxaparvovec for the Treatment of Hemophilia A in the United States
2024 · J Sarker, JA Tice, et al. · Value in Health
PDF
EE503 Cost Implications of Hospice Care for Cancer Patients in Illinois Hospitals
2022 · S Walton, T Johnson · Value in Health
Dm2 Adherence to Dpp-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients With Chronic Kidney Disease: a Retrospective Claims Database Analysis
2019 · D. Gor, T.A. Lee, et al. · Value in Health
Implementation Lessons Regarding Integrated Community Education for Children with Asthma
2019 · M.A. Martin, G. Rosales, et al. · American Journal of Respiratory and Critical Care Medicine
Pnd67 - Are New Preventive Migraine Drugs Cost-effective for Patients With Chronic and Episodic Migraine for Whom Other Preventive Medications Had Failed?
2018 · D Quach, TA Lee, et al. · Value in Health
Comparative effectiveness and safety of Argatroban and Bivalirudin in Patients with suspected Heparin-induced Thrombocytopenia
2015 · V.A. Patel, W.L. Galanter, et al. · Value in Health
PDF
PMH73 Estimating Off-Label Use of Prescription Drugs: The Case of Gabapentin
2012 · N. Khan, R. Kaestner, et al. · Value in Health
Pcv95 Using Computerized Physician Order Entry of Anti-hypertensive Medications to Connect Indications With Prescribing and Improve Problem List Documentation
2011 · W. Galanter, S. Walton, et al. · Value in Health
Works count: 9
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type